Factor XI, a potential target for anticoagulation therapy for venous thromboembolism

Venous thromboembolism (VTE) is a common cause of mortality and disability in hospitalized patients, and anticoagulation is an essential therapeutic option. Despite the increasing use of direct oral anticoagulants, complications and adverse drug reactions still occur in patients with VTE. Within 5 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tingting, Liu, Jiang, Wu, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659736/
https://www.ncbi.nlm.nih.gov/pubmed/36386334
http://dx.doi.org/10.3389/fcvm.2022.975767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659736/
https://www.ncbi.nlm.nih.gov/pubmed/36386334
http://dx.doi.org/10.3389/fcvm.2022.975767

Ejemplares similares